Clinical Management Guidelines for Intrahepatic Cholestasis of Pregnancy  

作　　者：Obstetrics Group of the Gynecology and Obstetrics Branch of Chinese Medical Association Perinatal Medicine Branch of Chinese Medical Association Xinyang Yu Huixia Yang Hongbo Qi 

机构地区：[1]不详 [2]Medical University,Chongqing 400016,China [3]Department of Obstetrics and Gynecology,Peking University First Hospital,Beijing 100034,China [4]Department of Obstetrics and Gynecology,Women and Children's Hospital of Chongqing Medical University,Chongqing 401147,China

出　　处：《Maternal-Fetal Medicine》2024年第1期13-22,共10页母胎医学杂志（英文）

基　　金：supported by National Key Research and Development Program of China (2022YFC2704702).

摘　　要：Intrahepatic cholestasis of pregnancy(ICP)is a significant gestational complication in late pregnancy,potentially leading to severe perinatal complications such as intrauterine fetal demise and preterm birth.The Obstetrics Group of the Gynecology and Obstetrics Branch and the Perinatal Medicine Branch of the Chinese Medical Association organized a panel of domestic experts to deliberate and propose recommendations based on domestic and international guidelines,recent evidence-based medical evidence about key clinical issues including risk factors,clinical manifestations,perinatal outcomes,diagnosis,severity grading,maternal and fetal monitoring,treatment methods,timing,and methods of pregnancy termination,and postpartum follow-up for ICP,with the aim to guide its clinical diagnosis,treatment,and management.

关 键 词：Cholestasis Intrahepatic Bile Acids STILLBIRTH Preterm Birth Diagnostic and Therapeutic Guidelines(Theme) 

分 类 号：R714.255[医药卫生—妇产科学]